Search

Author/Creator Kiewitz, C.

1. 2754 First interim analysis of OTILIA, a large German non-interventional study evaluating front-line bevacizumab (BEV)-containing therapy in patients with ovarian cancer (OC). (September 2015)

Authors:
Mustea, A.; Oskay-Oezcelik, G.; Wimberger, P.; Reichert, D.; Forstbauer, H.; Keller, M.; Frank, M.; Klawitter, S.; Kiewitz, C.; Mueller, M.; Sehouli, J.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search